Generation of an in vitro model for peripheral neuropathy in Fabry disease using CRISPR-Cas9 in the nociceptive dorsal root ganglion cell line 50B11

Fabry disease is a glycosphingolipid storage disorder that is caused by a genetic deficiency of the lysosomal enzyme alpha-galactosidase A (AGA, EC 3.2.1.22). As a result, the glycolipid substrate, globotriaosylceramide (Gb3) accumulates in various cell types throughout the body producing a multisys...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneski, Christine R., Hanover, John A., Schueler Hoffman, Ulrike H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248215/
https://www.ncbi.nlm.nih.gov/pubmed/35782611
http://dx.doi.org/10.1016/j.ymgmr.2022.100871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248215/
https://www.ncbi.nlm.nih.gov/pubmed/35782611
http://dx.doi.org/10.1016/j.ymgmr.2022.100871

Ejemplares similares